U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07563608) titled 'Prevalence, Pathogenesis, and Prognosis of Pulmonary Hypertension in Dialysis Patients' on April 22.
Brief Summary: This prospective multicenter longitudinal study aims to investigate the prevalence, pathogenesis, and prognosis of pulmonary hypertension in patients with end-stage renal disease undergoing chronic hemodialysis. The research seeks to identify specific clinical factors and biomarkers like angiopoietin-2 that contribute to the development of this condition, while evaluating the prognostic value of right ventricular function measured via TAPSE. Participants undergo a standardized screening echocardiogram the day after their...